Advertisement

Topics

Cancer Corporate

21:03 EST 24th November 2017 | BioPortfolio

Cigna Corporation and Good Samaritan Health System

The Good Samaritan Health System, which includes Regional Medical Center of San Jose and Good Samaritan Hospital-as well as three surgical centers and three Care Now Urgent Care centers, is committed to providing quality healthcare to residents throughout the greater Silicon Valley community. Good Samaritan Health provides a host of technologically-advance...

Universal Diagnostics

Universal Diagnostics (UDX) is an innovative biomedicine company focused on early detection of cancer. By combining world-leading expertise in metabolomics with advanced bioinformatics, UDX is developing simple to use, non-invasive tests to detect cancers early. The first test in development is for the detection of colorectal cancer and precancerous adenom...

Friends of Cancer Patients (FoCP)

Numenta

Numenta scientists and engineers are working on one of science’s grand challenges: how the brain works and how brain principles will be used in Machine Intelligence. Founded in 2005, Numenta is developing a theory of how the neocortex works. We create software technologies based on this theory and apply them to machine learning applications for continuously ...

BMG Pharma S.r.l.

BMG Pharma S.r.l. is a specialty pharmaceutical company with its head office in Milan, Italy, leveraging its proprietary technology to develop products that address unmet needs for patients. The Company is currently focused on partnering its product portfolio in cancer supportive care, dermatology, anaemia, gynaecology and oral / nasal care. BMG Pharma S.r...

CURE Connections®

A subsidiary of CURE Media Group, CURE Connections® provides a video platform for patients with cancer to share information, stories and advice about their cancer journey. CURE Media Group combines science and humanity to make cancer understandable. CURE Media Group is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc., family o...

Immunomic Therapeutics, Inc. (ITI)

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company headquartered in Hershey, PA with lab facilities in Rockville, MD. ITI is developing next generation vaccines based on its patented LAMP™ Technology platform. LAMP-Vax™ vaccine technology has the potential to significantly increase the effectiveness of the...

Arcus Biosciences

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which in February 2015 was acquired by Bristol-Myers Squibb to access Flexus’s IDO inhibitor, which was in preclinical...

Northern Biologics Inc.

Northern Biologics was launched in June 2014 from Blueline Bioscience, a Canadian biotechnology incubator operated by venture capital firm Versant Ventures, in partnership with the University of Toronto and University Health Network’s Princess Margaret Cancer Centre. Headquartered in the MaRS Discovery District of Toronto, the company is developing a ...

Brain Power, LLC

Brain Power is a neuro-tech company focused on innovative wearable technology to help people with brain-related challenges. Its technology is based on neuroscience developed at Harvard and MIT, evidence-based educational gamification techniques, AI, and AR. Brain Power’s flagship product, Empower Me, helps people on the autism spectrum overcome social ...

Progenity Inc.

Progenity is a biotechnology company with a market-leading presence in Women’s Health molecular testing and a pipeline of proprietary tests and therapeutic applications under development. Progenity has a portfolio of innovative technologies and tests for pre-eclampsia, genetic carrier testing, inheritable cancer genetics, liquid biopsy and noninvasive ...

OncoResponse

OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. Our most advanced program, ONCR-201 is an anti-EMP2 fully-human monoclonal antibody being developed for female malignancies. The OncoResponse discovery engine is working to increase the success rate of cancer immunotherapies by ident...

MORE Health

Headquartered in the Silicon Valley, MORE Health provides patients with access to the best physicians in the world when needed the most: when patients are faced with a critical, potentially life-changing illness, such as cancer or heart disease. Our collaborative approach to diagnosis puts the patient at the center of the process – empowering them to make ...

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals is pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of disease-driving genes. Syros has built a proprietary platform that is designed to systematically and efficiently analyze this unexploited region of DNA in human disease tissue to identify and drug novel ...

Gateway for Cancer Research

CBT Pharmaceuticals

CBT Pharmaceuticals is a life sciences company developing innovative oncology therapeutics targeting the growth and proliferation of cancer cells. The company is advancing a pipeline of four development-stage assets including CBT-101, an oral c-Met inhibitor targeting the epithelial-mesenchymal transition (EMT) pathway in cancers and CBT-501, a novel human...

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide ...

GeneCentric Therapeutics

GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable development of precision medicine drugs and improve patient outcomes. Our approach applies the Cancer Subtype Platform (CSP®) to parse complex tumor biology into genomic signatures revealing high-resolution cancer subtypes, with potential as un...

Harpoon Therapeutics, Inc.

Harpoon Therapeutics is an immuno-oncology company founded by Patrick Baeuerle, Ph.D., a pioneer in the development of T-cell engaging therapies, and MPM Capital. The company is focused on the discovery and development of novel T-cell engaging biologics for the treatment of cancer and other diseases. Harpoon Therapeutics created a novel T-cell recruiting d...

Translational Drug Development (TD2) and Minneamrita Therapeutics LLC

Minneamrita is an early clinical stage drug development company developing the molecules for unmet cancer treatments. Minneamrita is developing Minnelide for its use in various cancers (gastric, pancreatic, breast and AML).

CURE Magazine

CURE magazine, a member of the US Oncology family, is a free, award-winning publication from Dallas-based CURE Media Group - the national source for cancer patient education. By combining science and humanity, CURE helps patients, survivors and caregivers navigate the cancer journey and understand their diagnosis and treatment, while providing tools to cope during and after cancer - ultimately he...

Neural Analytics, Inc.

Neural Analytics was founded in 2013 to create products and services to measure, diagnose and track brain health. The company’s current focus is on acute ischemic stroke, TBI and dementia. They combine leading data science with cutting edge hardware to allow first responders and clinicians to accurately assess and monitor brain health issues. Their de...

Dune Medical Devices Ltd

Dune Medical Devices is engaged in the development and commercialization of highly advanced, real-time, tissue characterization devices. Dune's devices enable complete, residual-free, therapeutic excisions.Led by a team of medical device veterans Dune Medical has developed a powerful platform technology for real-time identification and localization of sub-millimeter cancer cell clusters. Embedded ...

Freenome

Headquartered in South San Francisco, Freenome is a health technology company developing accurate, accessible and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. Freenome aims to reinvent disease management through early detection and intervention. Since launching in 2014, the comp...

Quick Search
Advertisement
 

review and buy Cancer market research data and corporate reports here